中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
12期
16-17
,共2页
脓毒症%血必净%凝血功能%APACHEⅡ评分
膿毒癥%血必淨%凝血功能%APACHEⅡ評分
농독증%혈필정%응혈공능%APACHEⅡ평분
Sepsis%Xuebijing%Coagulation function%APACHE Ⅱscore
目的：探讨血必净对于提高脓毒症治愈率及改善凝血功能的积极作用。方法选取该院2012年9月—2013年9月间收治的50例脓毒症患者纳入研究。两组均采取常规综合治疗方案。研究组同时静滴血必净治疗。结果 APACHEⅡ评分（治疗前/治疗后24 h/治疗后72 h）：对照组为（18.36±4.66）分/（17.37±4.46）分/（14.58±3.66）分；研究组为（18.33±4.52）分/（15.62±4.12）分/（12.31±3.35）分。治疗后24 h及72 h，两组评分均下降，研究组评分低于对照组（P均＜0.05）。对照组转归率为84.0%（21例），研究组转归率为92.0%（P＞0.05）。血凝指标变化：治疗前两组各指标均差异无统计学意义（P＞0.05）。治疗后研究组各项指标均明显改善（P＜0.05）；对照组除TT外其他指标均明显改善（P＜0.05）。其中研究组PLT、APTT、PT、TT及FIB指标优于对照组（P＜0.05）。结论运用扶正攻邪，卫气营血理论，联合应用血必净能够有效提高脓毒症临床疗效，纠正其病理过程及异常凝血。
目的：探討血必淨對于提高膿毒癥治愈率及改善凝血功能的積極作用。方法選取該院2012年9月—2013年9月間收治的50例膿毒癥患者納入研究。兩組均採取常規綜閤治療方案。研究組同時靜滴血必淨治療。結果 APACHEⅡ評分（治療前/治療後24 h/治療後72 h）：對照組為（18.36±4.66）分/（17.37±4.46）分/（14.58±3.66）分；研究組為（18.33±4.52）分/（15.62±4.12）分/（12.31±3.35）分。治療後24 h及72 h，兩組評分均下降，研究組評分低于對照組（P均＜0.05）。對照組轉歸率為84.0%（21例），研究組轉歸率為92.0%（P＞0.05）。血凝指標變化：治療前兩組各指標均差異無統計學意義（P＞0.05）。治療後研究組各項指標均明顯改善（P＜0.05）；對照組除TT外其他指標均明顯改善（P＜0.05）。其中研究組PLT、APTT、PT、TT及FIB指標優于對照組（P＜0.05）。結論運用扶正攻邪，衛氣營血理論，聯閤應用血必淨能夠有效提高膿毒癥臨床療效，糾正其病理過程及異常凝血。
목적：탐토혈필정대우제고농독증치유솔급개선응혈공능적적겁작용。방법선취해원2012년9월—2013년9월간수치적50례농독증환자납입연구。량조균채취상규종합치료방안。연구조동시정적혈필정치료。결과 APACHEⅡ평분（치료전/치료후24 h/치료후72 h）：대조조위（18.36±4.66）분/（17.37±4.46）분/（14.58±3.66）분；연구조위（18.33±4.52）분/（15.62±4.12）분/（12.31±3.35）분。치료후24 h급72 h，량조평분균하강，연구조평분저우대조조（P균＜0.05）。대조조전귀솔위84.0%（21례），연구조전귀솔위92.0%（P＞0.05）。혈응지표변화：치료전량조각지표균차이무통계학의의（P＞0.05）。치료후연구조각항지표균명현개선（P＜0.05）；대조조제TT외기타지표균명현개선（P＜0.05）。기중연구조PLT、APTT、PT、TT급FIB지표우우대조조（P＜0.05）。결론운용부정공사，위기영혈이론，연합응용혈필정능구유효제고농독증림상료효，규정기병리과정급이상응혈。
Objective To discuss the positive effect of Xuebijing on improving the cure rate of sepsis and coagulation function. Methods 50 cases of patients with sepsis admitted in our hospital from September, 2012 to September, 2013 were included in the study. Both groups were given the routine comprehensive treatment. In addition, the study group was given intravenous drip of Xuebijing. Results The score of APACHE Ⅱ before treatment, 24h after treatment and 72h after treatment of the control group was (18.36±4.66) points, (17.37±4.46) points, (14.58±3.66) points, respectively, and that of the study group was (18.33±4.52) points, (15.62±4.12) points, (12.31±3.35) points, separately. 24 h and 72 h after treatment, the scores of both groups decreased;the scores of the study group were significantly lower than those of the control group (all P<0.05). The improvement rate was 84.0% in the control group (21 cases), 92.0% in the study group (P>0.05). Hemagglutination indexes' changes: before treatment, there were no statistically significant differences between two groups in hemagglutination indexes (P>0.05). After treatment, all the hemaggluti-nation indexes of the study group significantly improved(P<0.05), and hemagglutination indexes of the control group except TT sig-nificantly improved (P<0.05). PLT, APTT, PT, TT and FIB index of the study group were superior to those of the control group (P<0.05) Conclusion The application of fuzhenggongxie and weiqiyingxue theory combined with Xuebijing can effectively improve the clinical efficacy for sepsis, correct its pathological and abnormal blood clotting process.
